APA (7th ed.) Citation

Zhang, S., Afshar, H., Colvonen, P. J., Nokes, B., Compton, J., Mishra, J., . . . Koloski, M. F. (2025). Impact of Medical Comorbidities on Ketamine and Esketamine Treatment Effectiveness for Posttraumatic Stress Disorder and Depression: A Clinical Outcomes Analysis from the VA San Diego Healthcare System. CNS drugs, 39(6), 609-619. https://doi.org/10.1007/s40263-025-01180-w

Chicago Style (17th ed.) Citation

Zhang, Sijia, Houtan Afshar, Peter J. Colvonen, Brandon Nokes, Jason Compton, Jyoti Mishra, Andrew W. Bismark, Dhakshin S. Ramanathan, and Miranda F. Koloski. "Impact of Medical Comorbidities on Ketamine and Esketamine Treatment Effectiveness for Posttraumatic Stress Disorder and Depression: A Clinical Outcomes Analysis from the VA San Diego Healthcare System." CNS Drugs 39, no. 6 (2025): 609-619. https://doi.org/10.1007/s40263-025-01180-w.

MLA (9th ed.) Citation

Zhang, Sijia, et al. "Impact of Medical Comorbidities on Ketamine and Esketamine Treatment Effectiveness for Posttraumatic Stress Disorder and Depression: A Clinical Outcomes Analysis from the VA San Diego Healthcare System." CNS Drugs, vol. 39, no. 6, 2025, pp. 609-619, https://doi.org/10.1007/s40263-025-01180-w.